KLOW 80MG

$140.00

Description

KLOW Multi-Peptide Blend | KPV + BPC-157 + TB-500 + GHK-Cu | Research Grade

 

KLOW – Advanced Multi-Peptide Research Blend

KLOW is a strategically combined multi-peptide research formulation designed to explore the synergistic interaction of four advanced compounds: KPV, BPC-157, TB-500, and GHK-Cu.

This formulation brings together peptides commonly studied in research for their roles in system balance, tissue support, recovery pathways, and cellular signaling—offering a comprehensive approach to multi-pathway exploration.


Why KLOW Stands Out

Rather than studying compounds individually, KLOW allows for the exploration of how multiple peptide pathways may interact simultaneously. This provides a broader, more integrated perspective on biological signaling and response.


The 4-Peptide Synergy

KPV (Lysine-Proline-Valine)
Commonly discussed in research related to immune signaling, inflammatory pathway balance, and gut-related studies.

BPC-157
Widely referenced in research involving tissue support, structural pathways, and digestive system research.

TB-500 (Thymosin Beta-4 Fragment)
Commonly studied for cellular migration, systemic signaling, and mobility-related pathways.

GHK-Cu (Copper Peptide)
Well-known in research for its association with collagen pathways, skin-related studies, and cellular regeneration.


The KLOW Advantage – Combined Action

KLOW is designed to explore how these peptides interact together:

  • KPV supports internal signaling balance
  • BPC-157 focuses on localized structural pathways
  • TB-500 expands into systemic signaling
  • GHK-Cu contributes to cellular renewal research

Together, they create a multi-layered research model across multiple biological systems.


Designed for Advanced Research

KLOW is ideal for research involving:

  • Multi-pathway peptide interaction
  • System balance and recovery models
  • Gut and structural pathway studies
  • Cellular signaling exploration

COA

Certificates of Analysis

Shopping Cart

Select Your Age

Please confirm that you are 21 years of age or older before entering this website.

Access Denied

Sorry, you must be at least 21 years old to access this website.